Flu vaccines pass €1 billion in Sanofi-Aventis's Q4
This article was originally published in Scrip
Sanofi-Aventis has reported a 10% increase in its fourth-quarter net income as sales of its influenza vaccines grew to almost €1.1 billion. The French firm's human vaccines business expanded by 65% in the quarter, pushing group net income to €1.8 billion. More to follow.